SearchDictionaryMobileLogin

Animal Mammary Neoplasms

Subscribe to Selected New Research on Animal Mammary Neoplasms
61  relevant articles (0 outcomes, 7 trials/studies) found for this Disease

Description: Tumors or cancer of the MAMMARY GLAND in animals (MAMMARY GLANDS, ANIMAL).

Also Known As:
Mammary Neoplasms, Animal; Animal Mammary Carcinoma; Mammary Carcinoma, Animal; Mammary Neoplasms; Neoplasms, Mammary; Animal Mammary Carcinomas; Animal Mammary Neoplasm; Carcinoma, Animal Mammary; Carcinomas, Animal Mammary; Mammary Carcinomas, Animal; Mammary Neoplasm; Mammary Neoplasm, Animal; Neoplasm, Animal Mammary; Neoplasm, Mammary; Neoplasms, Animal Mammary

Disease Context: Research Results

-
Neoplasms: 387349
-
Neoplasms by Site: 1
-
Animal Mammary Neoplasms: 61
*
Experimental Mammary Neoplasms: 1
-
Animal Diseases: 110
*
Animal Mammary Neoplasms: 61

Related Diseases

1. Neoplasms (Cancer)
2. Breast Neoplasms (Breast Cancer)
3. Neoplasm Metastasis (Metastasis)
4. Infection
5. Hyperplasia

Experts

1. Fytianou, A: 2 articles (09/2006 - 12/2003)
2. Roubies, N: 2 articles (09/2006 - 12/2003)
3. Kaldrymidou, E: 2 articles (09/2006 - 12/2003)
4. Koutinas, A F: 2 articles (09/2006 - 12/2003)
5. Karayannopoulou, M: 2 articles (09/2006 - 12/2003)
6. Polizopoulou, Z S: 2 articles (09/2006 - 12/2003)
7. Constantinidis, T C: 1 article (09/2006)
8. Koutinas, C K: 1 article (09/2006)
9. Tsioli, V: 1 article (09/2006)
10. Patsikas, M N: 1 article (09/2006)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Animal Mammary Neoplasms:
1. HormonesIBA
2. Peanut AgglutininIBA
3. ConnexinsIBA
4. Steroid Receptors (Steroid Receptor)IBA
5. Fibronectins (Fibronectin)IBA
6. Contraceptive Agents (Contraceptives)IBA
7. CarcinogensIBA
8. Differentiation AntigensIBA
01/01/2004 - "METHODS: Expression patterns for terminal differentiation markers were used to characterize tumor types and to study tumor progression in transgenic mouse models of mammary neoplasia (mice overexpressing Neu (Erbb2), Hras, Myc, Notch4, SV40-TAg, Tgfa, and Wnt1), in spontaneous mammary carcinomas, and in mammary neoplasms associated with infection by the mouse mammary tumor virus (MMTV)"
01/01/2004 - "Immunolabeling for terminal differentiation markers was compared among a variety of mouse mammary neoplasms because expression of terminal differentiation markers, and especially of keratins, provides important information on the origin of neoplastic cells and their degree of differentiation"
01/01/2004 - "RESULTS: On the basis of the expression of terminal differentiation markers, three types of neoplasm were identified: first, simple carcinomas composed exclusively of cells with a luminal phenotype are characteristic of neoplasms arising in mice transgenic for Neu, Hras, Myc, Notch4, and SV40-TAg; second, 'complex carcinomas' displaying luminal and myoepithelial differentiation are characteristic of type P tumors arising in mice transgenic for Wnt1, neoplasms arising in mice infected by the MMTV, and spontaneous adenosquamous carcinomas; and third, 'carcinomas with epithelial to mesenchymal transition (EMT)' are a characteristic feature of tumor progression in Hras-, Myc-, and SV40-TAg-induced mammary neoplasms and PL/J and SJL/J mouse strains, and display de novo expression of myoepithelial and mesenchymal cell markers"
Order ALL the reference details at left...
9. tebufenozide (Mimic)IBA
10. 9,10-Dimethyl-1,2-benzanthracene (DMBA)IBA

Therapies and Procedures

1. Transplants (Transplant)
2. Drug Therapy (Chemotherapy)
3. X-Ray Therapy
4. Transplantation (Transplant Recipients)
5. Thymectomy

Best Treatments:
Research Summary Report
on Animal Mammary Neoplasms
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 0 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>